PKD Foundation Funds Millions in Groundbreaking New ResearchPKD Foundation scientific advisors have voted to fund approximately $4 million in PKD research, including a project in France studying a promising new drug, Roscovitine.
According to researchers, Roscovitine may provide a long-term treatment for PKD without frequent dosing. It is currently being used in cancer clinical trials.
For the first time, the PKD Foundation will also fund a research project at the Stowers Institute in Kansas City, home of the PKD Foundation's international headquarters.
This year, the PKD Foundation is funding projects in 17 states and 10 foreign countries.
Standard Grants: Year 1, $75,000 Each
Oregon Health and Science University in Portland, OR:
Estrogen metabolites and experimental polycystic kidney disease
PKD Information at Oregon Health and Science University
Brigham and Women's Hospital in Boston, MA:
Characterization of the role of the Nek8 kinase in development
PKD Information at Brigham and Women's Hospital
Harvard Medical School in Boston, MA:
TAZ as a possible substrate of Nek kinases
PKD Information at Harvard
University of Technology in Aachen, Germany:
Characterization of the PKHD1 gene and genotype-phenotype studies in autosomal recessive polycystic kidney disease (ARPKD)
Fondazione-Telethon Institute of Genetics and Medicine in Naples, Italy:
Elucidation of the role of OFD1 in renal cystic disease
PKD Information at Fondazione-Telethon Institute of Genetics
Indiana University in Indianapolis, IN:
Delivery of a human artificial chromosome harboring a PKD1 transgene into renal epithelial cells
PKD Information at Indiana University
Beth Israel Deaconess Medical Center in Boston, MA:
Stem cell therapy for polycystic kidney disease
PKD Information at Beth Israel Deaconess Medical Center
Stowers Institute for Medical Research in Kansas City, MO:
Histone deacetylases (HDACs) and Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PKD Information at Stowers
University of Michigan in Ann Arbor, MI:
Regulation of ciliary trafficking by RP2
PKD Information at University of Michigan
Centre National de la Recherche Scientifique (C.N.R.S.) in Roscoff, France:
Roscovitine-derived pharmacological inhibitors of cyclin-dependent kinases: optimization and characterization for PKD therapeutic application
PKD Information at C.N.R.S.
Leiden University Medical Center in Leiden, The Netherlands:
The role of TGFB-signaling in the progression of polycystic kidney disease
PKD Information at Leiden University Medical Center
Texas A&M in University College Station, TX:
Identification of effectors for the IFT27, an intraflagellar transport (IFT) particle protein functioning in the cell cycle
PKD Information at Texas A&M
The Mount Sinai School of Medicine in New York, NY:
Biomechanical transduction of gene transcription in renal tubular epithelia
PKD Information at Mount Sinai
Yale University in New Haven, CT:
Angiogenesis and progression of liver cysts in ADPKD
PKD Information at Yale
University of Iowa in Iowa City, IA:
Molecular mechanism of renal deciliation and cystogenesis
PKD Information at University of Iowa
Fellowships: Year 1, $50,000 Each
University of Massachusetts Medical School in Worchester, MA:
Primary role for the centrosome in cilia formation and ciliopathies
PKD Information at University of Massachusetts Medical School
Johns Hopkins University School of Medicine in Baltimore, MD:
Using induced PKD1 inactivation and network modeling strategies to identify gene networks responsible for post-natal kidney maturation and cystogenesis
PKD Information at Johns Hopkins
University of Kansas Medical Center, The Kidney Institute in Kansas City, KS:
Role of 14-3-3 and A-kinase anchoring proteins on the cAMP-dependent B-Raf signaling and proliferation of ADPKD cells
PKD Information at University of Kansas Medical Center
Children's Hospital of Boston in Boston, MA:
Regulation of pkd2 expression by α3β1 integrin
PKD Information at Children's Hospital
Cincinnati Children's Hospital Medical Center in Cincinnati, OH:
The role of primary cilia in regulating mammalian target of rapamycin signaling
PKD Information at Cincinnati Children's Hospital Medical Center
Brigham and Women's Hospital in Boston, MA:
Molecular mechanism of renal cystogenesis in ADPKD
PKD Information at Brigham and Women's Hospital
Young Investigator Career Development Awards: Year 1, $65,000 Each
The Johns Hopkins University School of Medicine in Baltimore, MD:
Polycystin signaling in Drosophila melanogaster
PKD Information at Johns Hopkins
The Penn State University in University Park, PA:
The roles for Inturned in kidney development and PKD pathogenesis
PKD Information at Penn State
Brigham and Women's Hospital in Boston, MA:
Molecular mechanisms of the autosomal recessive polycystic kidney disease
PKD Information at Brigham and Women's Hospital
Standard Grants: Year 2, $75,000 Each
Texas Tech University Health Sciences Center in Lubbock, TX:
The effect of inhibition of IL-8 and b-catenin on the evolution of in vivo and in vitro models of ADPKD
PKD Information at Texas Tech
Yale University School of Medicine in New Haven, CT:
Mechanism of polycystic liver disease in Hhex mutant mice
PKD Information at Yale
Fondazione Centro San Rafelle del Monte Tabor in Milan, Italy:
The role of polycystins in renal development
PKD Information at Fondazione
University of Texas Southwestern Medical Center in Dallas, TX:
The role of Wnt9b signaling in PKD
PKD Information at University of Texas Southwestern
Swiss Federal Institute of Technology in Lausanna, Switzerland:
The role of Bicc in PKD and cilia signaling
PKD Information at Swiss Federal Insititute of Technology
Yale University School of Medicine in New Haven, CT:
Molecular investigation of polycystin-2 regulation
PKD Information at Yale
Yale University School of Medicine in New Haven, CT:
Pathogenesis of congenital hepatic fibrosis and biliary cyst formation in ARPKD
PKD Information at Yale
Johns Hopkins School of Medicine in Baltimore, MD:
Novel interacting proteins of the PC1 plat domain
PKD Information at Johns Hopkins
University of Alabama at Birmingham in Birmingham, AL:
Identification of PKD markers: Transcriptome-profiling based approach
PKD Information at UAB
University of Sheffield School of Medicine in Sheffield, England:
The role of peroxisome proliferator activated receptor (PPAR)-gamma agonists in the progression of cystic and vascular phenotypes in ADPKD
PKD Information at University of Sheffield
Medical College of Wisconsin in Wauwatosa, WI:
The role of 20-HETE in polycystic kidney disease
PKD Informaiton at Medical College of Wisconsin
Johns Hopkins School of Medicine in Baltimore, MD:
Discovering extracellular ligands of polycystin-1
PKD Information at Johns Hopkins
Yale University School of Medicine in New Haven, CT:
The role of pontin in cilia assembly and cyst formation in zebrafish
PKD Information at Yale
University of California at San Francisco in San Francisco, CA:
CFTR-based therapy for PKD
PKD Information at UCSF
Purdue University in Indianapolis, IN:
Structural analysis of polycystin-2 cytoplasmic domain
PKD Information at Purdue
University of Alabama at Birmingham in Birmingham, AL:
Cilia and cAMP in cystic disease
PKD Information at UAB
USC Keck School of Medicine in Los Angeles, CA:
Role of claudin-7 in chloride an fluid secretion in PKD
PKD Information at USC
Fellowships: Year 2, $50,000
University of Texas MD Anderson Cancer Center in Smithville, TX:
Polycystin-1 regulation of the TSC2 tumor suppressor tuberin
PKD Information at University of Texas MD
Yale University School of Medicine in New Haven, CT:
The biflagellate Chlamydomonas as a model cell for studying PKD2 function
PKD Information at Yale
University of Texas in Galveston, TX:
Genome-wide combinatoril analysis of HNF-1b target genes in kidney
PKD Information at University of Texas Galveston
Hokkaido University School of Medicine in Hokkaido, Japan:
Molecular genetic basis of kidney and liver cyst formation in ADPLD
PKD Information at Hokkaido University
Massacusetts General Hospital in Boston, MA:
The role of HNF-1b in renal development and PKD, and isolation of novel PKD drugs using zebrafish as a disease model
PKD Information at Massachusetts General
Beth Israel Hospital, Harvard Medical School in Boston, MA:
Role of ATP in shear stress-induced Ca signaling in human kidney cells
PKD Information at Harvard
Core Grants: Year 2, $44,000
Mayo Clinic in Rochester, MN:
ADPKD Gene Mutation Registry
PKD Information at Mayo
Collaborative Grants: Year 2, $37,500 Each
Institute of Medical Genetics, Cardiff University in Cardiff, UK:
Investigating the relationship between tuberous sclerosis and PKD using mouse models
PKD Information at Institute of Medical Genetics
Fox Chase Cancer Center in Philadelphia, PA:
Roles of tuberin (TSC2) and Rheb in cystic kidney disease
PKD Information at Fox Chase Cancer Center
University of Texas MD Anderson Cancer Center in Houston, TX:
C-SRC regulation of the functional PKD-1 TSC2 interation
PKD Information at University of Texas MD
Translational Grants: Year 2, $100,000 Each
Mayo Clinic in Rochester, MN:
Evaluation and treatment of chronic pain in ADPKD
PKD Information at Mayo
Mayo Clinic in Rochester, MN:
Treatment of polycystic liver disease
PKD Information at Mayo
Mario Negri Institute in Bergamo, Italy:
Effect of long acting somatostatin on disease progression in ADPKD: A long-term three year follow-up study
PKD Information at Mario Negri Institute
Posted February 7, 2008
http://www.pkdfoundation.org/